0478 Better Best: European Pharmacopoeia Ph Eur Monograph Tablets
Which specific (e.g., modified-release, effervescent) you are targeting.
This test is performed during product development to validate the tablet's design. The strict limits ensure that a patient splitting a tablet receives a dose that is highly accurate, regardless of which half they take.
The new approach harmonizes with ICH Q6A guidelines , requiring a product-specific dissolution test to be included in the marketing authorization application for routine quality control.
It ensures consistent batch-to-batch quality, directly impacting the bio-availability of the medication, rather than relying solely on disintegration time. 3. Improved Uniformity of Dosage Units european pharmacopoeia ph eur monograph tablets 0478 better
Requires testing a random sample of 20 tablets. Compliance is achieved if no more than 2 individual masses deviate by more than the specified percentage from the average mass, and none deviate by more than double that percentage.
: Uses precise quantitative assays to verify that individual tablets contain the specified amount of API, which is critical for low-dose or highly potent drugs.
If you need to expand on a specific section of this article, please let me know: Which specific (e
Acknowledging difficulty is important. 0478 is "better" precisely because it is harder to cheat or misinterpret.
These tests assess the physical integrity of the tablet. Friability measures the tablet's ability to withstand abrasion during packaging and transport, while crushing strength ensures it doesn't crumble during handling but remains soft enough to disintegrate. Categorization of Tablets
Common mistake: Using USP parameters for a Ph. Eur. submission. The new approach harmonizes with ICH Q6A guidelines
Mandatory for tablets with active substance content less than 2 mg or less than 2% of the total mass.
The updated requirements make it clear that, unless otherwise justified, tablets must adhere to strict 15% deviation limits in mass uniformity tests.
According to the monograph and related general chapters, tablets must meet specific criteria for safety and efficacy: